First Page | Meta Content | |
---|---|---|
Document Date: 2013-06-05 01:02:26Open Document File Size: 476,43 KBShare Result on FacebookCompanyCelsense Inc. / /FacilityCarnegie Mellon University / University of Pittsburgh Cancer Institute / /IndustryTermstudy management / patient‐monitoring protocol / web‐based software / cellular product / cellular products / In vivo imaging platform / non‐invasive imaging methods / magnetic resonance imaging / Non‐invasive imaging / transition metal contrast agents / cell quantification tools / therapeutic product / animal systems / quantitative imaging modality / detailed protocols / imaging / magnetic resonance imaging cell tracking / cell handling protocols / cloud‐computing / /MedicalConditioninflammatory bowel disease / cancer / HIV / disease / J. Cancer / stroke / diabetes / pancreatitis / human diseases / inflammation / /MedicalTreatmentimmunotherapy / radiation / /OrganizationUniversity of Pittsburgh Cancer Institute / FDA / Carnegie Mellon University / FDA’s Cellular / Tissue and Gene Therapy Advisory Committee / /PersonNat / /TechnologyGene Therapy / radiation / Biomaterials / patient‐monitoring protocol / magnetic resonance imaging / transplantation / stem cells / existing cell handling protocols / regenerative medicine / MRI / not hence affording the involve ionizing radiation / performed using 19F MRI / /URLwww.celsense.com / /SocialTag |